Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells

Stem cell-based therapy has the potential to treat an array of human diseases. However, to study the therapeutic potential and safety of these cells, a scalable cell culture medium is needed that is free of human or bovine-derived serum proteins. Thus, cost-effective recombinant serum proteins and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioengineered 2014-05, Vol.5 (3), p.180-185
Hauptverfasser: Alfano, Randall, Youngblood, Bradford A, Zhang, Deshui, Huang, Ning, MacDonald, Clinton C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 185
container_issue 3
container_start_page 180
container_title Bioengineered
container_volume 5
creator Alfano, Randall
Youngblood, Bradford A
Zhang, Deshui
Huang, Ning
MacDonald, Clinton C
description Stem cell-based therapy has the potential to treat an array of human diseases. However, to study the therapeutic potential and safety of these cells, a scalable cell culture medium is needed that is free of human or bovine-derived serum proteins. Thus, cost-effective recombinant serum proteins and cytokines are needed to produce such mediums. One such cytokine, leukemia inhibitory factor (LIF), has been shown to be a critical paracrine factor that maintains stem cell pluripotency in murine embryonic stem cells and human naïve stem cells while simultaneously inhibiting differentiation. We recently produced recombinant human LIF (rhLIF) in a rice-based protein expression system known as ExpressTec. 12 We described expression of rice-derived rhLIF and demonstrated its biological equivalency to E. coli-derived rhLIF in traditional and embryonic mouse stem cell systems. Here we describe the expression yield of rice-derived rhLIF and the scale up production capacity. We provide further evidence of the efficacy of rice-derived rhLIF in additional stem cell systems including human neural stem cells and mouse induced pluripotent stem (iPS) cells. The expression level, biological activity, and potential for production at commercial scale of rice-derived rhLIF provides a proof-of-principal for ExpressTec-derived proteins to produce regulatory-friendly, high performance, and dependable stem cell media.
doi_str_mv 10.4161/bioe.28996
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_4161_bioe_28996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1546214160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-e405e50f6909f2edf9fafe663ef9fd5f500461f7819abb2668b66bf2828fe08e3</originalsourceid><addsrcrecordid>eNptkUFr3DAQhU1paEKSS39AmWNa2K3klWX7UighaQoLuSRnIdujWq0luZK8rfub8iMrZ9MlhaDDDOjjvTe8LHtLyZpRTj822uE6r-qav8pOcsqLVVFX5evDXtbH2XkI3wkhlGxYUVZvsuOclSWvK3aSPdxMRloYcPqBRkvQtteNjs7PoGSbJozedVOLHTQzxB7h6vfoMYQ7bMFg7F0HyjsDXrcIF7d-_iMhyKh3Erbr96ADJBm9w6QM_aOXxcnLAUJEAy0OQyJsB8ZNYYH2XuMweT26iDY-A8-yIyWHgOdP8zS7v766u7xZbW-_fL38vF21LGdxhYwUWBDFa1KrHDtVK6mQ8w2mrStUQQjjVJUVrWXT5JxXDeeNyqu8Ukgq3Jxmn_a649QY7NqUIiUWo9dG-lk4qcX_P1b34pvbCUbJ8pLAxZOAdz8nDFEYHZYTpMV0p6AF4zlN_S3ohz3aeheCR3WwoUQsDYulYfHYcILfPQ92QP_1mYBiD2irnDfyl_NDJ6KcB-eVl7bVQWxeEP4Lg6i5KA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1546214160</pqid></control><display><type>article</type><title>Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Alfano, Randall ; Youngblood, Bradford A ; Zhang, Deshui ; Huang, Ning ; MacDonald, Clinton C</creator><creatorcontrib>Alfano, Randall ; Youngblood, Bradford A ; Zhang, Deshui ; Huang, Ning ; MacDonald, Clinton C</creatorcontrib><description>Stem cell-based therapy has the potential to treat an array of human diseases. However, to study the therapeutic potential and safety of these cells, a scalable cell culture medium is needed that is free of human or bovine-derived serum proteins. Thus, cost-effective recombinant serum proteins and cytokines are needed to produce such mediums. One such cytokine, leukemia inhibitory factor (LIF), has been shown to be a critical paracrine factor that maintains stem cell pluripotency in murine embryonic stem cells and human naïve stem cells while simultaneously inhibiting differentiation. We recently produced recombinant human LIF (rhLIF) in a rice-based protein expression system known as ExpressTec. 12 We described expression of rice-derived rhLIF and demonstrated its biological equivalency to E. coli-derived rhLIF in traditional and embryonic mouse stem cell systems. Here we describe the expression yield of rice-derived rhLIF and the scale up production capacity. We provide further evidence of the efficacy of rice-derived rhLIF in additional stem cell systems including human neural stem cells and mouse induced pluripotent stem (iPS) cells. The expression level, biological activity, and potential for production at commercial scale of rice-derived rhLIF provides a proof-of-principal for ExpressTec-derived proteins to produce regulatory-friendly, high performance, and dependable stem cell media.</description><identifier>ISSN: 2165-5979</identifier><identifier>EISSN: 2165-5987</identifier><identifier>DOI: 10.4161/bioe.28996</identifier><identifier>PMID: 24776984</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Addendum ; Animals ; Biomarkers - metabolism ; Cell Differentiation - drug effects ; Codon ; embryonic stem cell ; Escherichia coli - genetics ; Escherichia coli - metabolism ; Gene Expression ; Glycosylation ; growth rate ; Homeodomain Proteins - genetics ; Homeodomain Proteins - metabolism ; Humans ; Induced Pluripotent Stem Cells - cytology ; Induced Pluripotent Stem Cells - drug effects ; Induced Pluripotent Stem Cells - metabolism ; Leukemia Inhibitory Factor - biosynthesis ; Leukemia Inhibitory Factor - genetics ; Leukemia Inhibitory Factor - pharmacology ; LIF ; Mice ; Nanog ; Nanog Homeobox Protein ; Neural Stem Cells - cytology ; Neural Stem Cells - drug effects ; Neural Stem Cells - metabolism ; Oct 4 ; Octamer Transcription Factor-3 - genetics ; Octamer Transcription Factor-3 - metabolism ; Oryza - genetics ; Oryza - metabolism ; Promoter Regions, Genetic ; recombinant protein expression ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - genetics ; Recombinant Proteins - pharmacology</subject><ispartof>Bioengineered, 2014-05, Vol.5 (3), p.180-185</ispartof><rights>Copyright © 2014 Landes Bioscience 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-e405e50f6909f2edf9fafe663ef9fd5f500461f7819abb2668b66bf2828fe08e3</citedby><cites>FETCH-LOGICAL-c424t-e405e50f6909f2edf9fafe663ef9fd5f500461f7819abb2668b66bf2828fe08e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101010/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101010/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24776984$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alfano, Randall</creatorcontrib><creatorcontrib>Youngblood, Bradford A</creatorcontrib><creatorcontrib>Zhang, Deshui</creatorcontrib><creatorcontrib>Huang, Ning</creatorcontrib><creatorcontrib>MacDonald, Clinton C</creatorcontrib><title>Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells</title><title>Bioengineered</title><addtitle>Bioengineered</addtitle><description>Stem cell-based therapy has the potential to treat an array of human diseases. However, to study the therapeutic potential and safety of these cells, a scalable cell culture medium is needed that is free of human or bovine-derived serum proteins. Thus, cost-effective recombinant serum proteins and cytokines are needed to produce such mediums. One such cytokine, leukemia inhibitory factor (LIF), has been shown to be a critical paracrine factor that maintains stem cell pluripotency in murine embryonic stem cells and human naïve stem cells while simultaneously inhibiting differentiation. We recently produced recombinant human LIF (rhLIF) in a rice-based protein expression system known as ExpressTec. 12 We described expression of rice-derived rhLIF and demonstrated its biological equivalency to E. coli-derived rhLIF in traditional and embryonic mouse stem cell systems. Here we describe the expression yield of rice-derived rhLIF and the scale up production capacity. We provide further evidence of the efficacy of rice-derived rhLIF in additional stem cell systems including human neural stem cells and mouse induced pluripotent stem (iPS) cells. The expression level, biological activity, and potential for production at commercial scale of rice-derived rhLIF provides a proof-of-principal for ExpressTec-derived proteins to produce regulatory-friendly, high performance, and dependable stem cell media.</description><subject>Addendum</subject><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Codon</subject><subject>embryonic stem cell</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - metabolism</subject><subject>Gene Expression</subject><subject>Glycosylation</subject><subject>growth rate</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Humans</subject><subject>Induced Pluripotent Stem Cells - cytology</subject><subject>Induced Pluripotent Stem Cells - drug effects</subject><subject>Induced Pluripotent Stem Cells - metabolism</subject><subject>Leukemia Inhibitory Factor - biosynthesis</subject><subject>Leukemia Inhibitory Factor - genetics</subject><subject>Leukemia Inhibitory Factor - pharmacology</subject><subject>LIF</subject><subject>Mice</subject><subject>Nanog</subject><subject>Nanog Homeobox Protein</subject><subject>Neural Stem Cells - cytology</subject><subject>Neural Stem Cells - drug effects</subject><subject>Neural Stem Cells - metabolism</subject><subject>Oct 4</subject><subject>Octamer Transcription Factor-3 - genetics</subject><subject>Octamer Transcription Factor-3 - metabolism</subject><subject>Oryza - genetics</subject><subject>Oryza - metabolism</subject><subject>Promoter Regions, Genetic</subject><subject>recombinant protein expression</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - pharmacology</subject><issn>2165-5979</issn><issn>2165-5987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><recordid>eNptkUFr3DAQhU1paEKSS39AmWNa2K3klWX7UighaQoLuSRnIdujWq0luZK8rfub8iMrZ9MlhaDDDOjjvTe8LHtLyZpRTj822uE6r-qav8pOcsqLVVFX5evDXtbH2XkI3wkhlGxYUVZvsuOclSWvK3aSPdxMRloYcPqBRkvQtteNjs7PoGSbJozedVOLHTQzxB7h6vfoMYQ7bMFg7F0HyjsDXrcIF7d-_iMhyKh3Erbr96ADJBm9w6QM_aOXxcnLAUJEAy0OQyJsB8ZNYYH2XuMweT26iDY-A8-yIyWHgOdP8zS7v766u7xZbW-_fL38vF21LGdxhYwUWBDFa1KrHDtVK6mQ8w2mrStUQQjjVJUVrWXT5JxXDeeNyqu8Ukgq3Jxmn_a649QY7NqUIiUWo9dG-lk4qcX_P1b34pvbCUbJ8pLAxZOAdz8nDFEYHZYTpMV0p6AF4zlN_S3ohz3aeheCR3WwoUQsDYulYfHYcILfPQ92QP_1mYBiD2irnDfyl_NDJ6KcB-eVl7bVQWxeEP4Lg6i5KA</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Alfano, Randall</creator><creator>Youngblood, Bradford A</creator><creator>Zhang, Deshui</creator><creator>Huang, Ning</creator><creator>MacDonald, Clinton C</creator><general>Taylor &amp; Francis</general><general>Landes Bioscience</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140501</creationdate><title>Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells</title><author>Alfano, Randall ; Youngblood, Bradford A ; Zhang, Deshui ; Huang, Ning ; MacDonald, Clinton C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-e405e50f6909f2edf9fafe663ef9fd5f500461f7819abb2668b66bf2828fe08e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Addendum</topic><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Codon</topic><topic>embryonic stem cell</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - metabolism</topic><topic>Gene Expression</topic><topic>Glycosylation</topic><topic>growth rate</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Humans</topic><topic>Induced Pluripotent Stem Cells - cytology</topic><topic>Induced Pluripotent Stem Cells - drug effects</topic><topic>Induced Pluripotent Stem Cells - metabolism</topic><topic>Leukemia Inhibitory Factor - biosynthesis</topic><topic>Leukemia Inhibitory Factor - genetics</topic><topic>Leukemia Inhibitory Factor - pharmacology</topic><topic>LIF</topic><topic>Mice</topic><topic>Nanog</topic><topic>Nanog Homeobox Protein</topic><topic>Neural Stem Cells - cytology</topic><topic>Neural Stem Cells - drug effects</topic><topic>Neural Stem Cells - metabolism</topic><topic>Oct 4</topic><topic>Octamer Transcription Factor-3 - genetics</topic><topic>Octamer Transcription Factor-3 - metabolism</topic><topic>Oryza - genetics</topic><topic>Oryza - metabolism</topic><topic>Promoter Regions, Genetic</topic><topic>recombinant protein expression</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alfano, Randall</creatorcontrib><creatorcontrib>Youngblood, Bradford A</creatorcontrib><creatorcontrib>Zhang, Deshui</creatorcontrib><creatorcontrib>Huang, Ning</creatorcontrib><creatorcontrib>MacDonald, Clinton C</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioengineered</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alfano, Randall</au><au>Youngblood, Bradford A</au><au>Zhang, Deshui</au><au>Huang, Ning</au><au>MacDonald, Clinton C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells</atitle><jtitle>Bioengineered</jtitle><addtitle>Bioengineered</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>5</volume><issue>3</issue><spage>180</spage><epage>185</epage><pages>180-185</pages><issn>2165-5979</issn><eissn>2165-5987</eissn><abstract>Stem cell-based therapy has the potential to treat an array of human diseases. However, to study the therapeutic potential and safety of these cells, a scalable cell culture medium is needed that is free of human or bovine-derived serum proteins. Thus, cost-effective recombinant serum proteins and cytokines are needed to produce such mediums. One such cytokine, leukemia inhibitory factor (LIF), has been shown to be a critical paracrine factor that maintains stem cell pluripotency in murine embryonic stem cells and human naïve stem cells while simultaneously inhibiting differentiation. We recently produced recombinant human LIF (rhLIF) in a rice-based protein expression system known as ExpressTec. 12 We described expression of rice-derived rhLIF and demonstrated its biological equivalency to E. coli-derived rhLIF in traditional and embryonic mouse stem cell systems. Here we describe the expression yield of rice-derived rhLIF and the scale up production capacity. We provide further evidence of the efficacy of rice-derived rhLIF in additional stem cell systems including human neural stem cells and mouse induced pluripotent stem (iPS) cells. The expression level, biological activity, and potential for production at commercial scale of rice-derived rhLIF provides a proof-of-principal for ExpressTec-derived proteins to produce regulatory-friendly, high performance, and dependable stem cell media.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>24776984</pmid><doi>10.4161/bioe.28996</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2165-5979
ispartof Bioengineered, 2014-05, Vol.5 (3), p.180-185
issn 2165-5979
2165-5987
language eng
recordid cdi_crossref_primary_10_4161_bioe_28996
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Addendum
Animals
Biomarkers - metabolism
Cell Differentiation - drug effects
Codon
embryonic stem cell
Escherichia coli - genetics
Escherichia coli - metabolism
Gene Expression
Glycosylation
growth rate
Homeodomain Proteins - genetics
Homeodomain Proteins - metabolism
Humans
Induced Pluripotent Stem Cells - cytology
Induced Pluripotent Stem Cells - drug effects
Induced Pluripotent Stem Cells - metabolism
Leukemia Inhibitory Factor - biosynthesis
Leukemia Inhibitory Factor - genetics
Leukemia Inhibitory Factor - pharmacology
LIF
Mice
Nanog
Nanog Homeobox Protein
Neural Stem Cells - cytology
Neural Stem Cells - drug effects
Neural Stem Cells - metabolism
Oct 4
Octamer Transcription Factor-3 - genetics
Octamer Transcription Factor-3 - metabolism
Oryza - genetics
Oryza - metabolism
Promoter Regions, Genetic
recombinant protein expression
Recombinant Proteins - biosynthesis
Recombinant Proteins - genetics
Recombinant Proteins - pharmacology
title Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A36%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20leukemia%20inhibitory%20factor%20produced%20by%20the%20ExpressTec%20method%20from%20rice%20(Oryza%20sativa%20L.)%20is%20active%20in%20human%20neural%20stem%20cells%20and%20mouse%20induced%20pluripotent%20stem%20cells&rft.jtitle=Bioengineered&rft.au=Alfano,%20Randall&rft.date=2014-05-01&rft.volume=5&rft.issue=3&rft.spage=180&rft.epage=185&rft.pages=180-185&rft.issn=2165-5979&rft.eissn=2165-5987&rft_id=info:doi/10.4161/bioe.28996&rft_dat=%3Cproquest_cross%3E1546214160%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1546214160&rft_id=info:pmid/24776984&rfr_iscdi=true